Vimarsana
Biggest News Aggregation in the World

Intersectoral Collaboration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intersectoral Collaboration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intersectoral Collaboration Today - Breaking & Trending Today

Israel Heading Toward a Silenced, Paralyzed Society - Vimarsana News

Israel Heading Toward a Silenced, Paralyzed Society

The blow would be hardest for organizations whose role is to defend vulnerable groups, including; those living below the poverty line, the elderly, women, and people with disabilities.

Source: idi.org.il
Israel heading toward a silenced, paralyzed society - opinion - Vimarsana News

Israel heading toward a silenced, paralyzed society - opinion

The blow would be hardest for organizations whose role is to defend vulnerable groups, including; those living below the poverty line, the elderly, women, and people with disabilities.

Source: jpost.com
BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Pro - Vimarsana News

BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Pro

Research team ‘EDC’ will study ‘Extrachromosomal DNA in Cancer’.With this project, the two partners launch their ninth collaboration, seven of which have been in the field of oncology.HEIDELBERG, Germany, August 1, 2022 / B3C newswire / -- BioMed X, a German independent research institute, announces the start o...

BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology - Vimarsana News

BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

BioMed X announces the extension of its collaboration with Merck in the research project RNA Splicing in Cancer. Merck has decided to acquire the IP rights in the project results and to continue the project for another year. The goal of the extension is to further validate novel potential drug targets based on these results.